Cancer accounts for high morbidity and high mortality rate throughout the world. Cancer of breast is common in women in developed countries and more than 40% of all breast cancer cases are found in developing countries.
In addition to the therapeutic strategies already known, some recent reports indicate new areas for the development of target selective drugs for the treatment of metastatic breast cancer.
3) The earliest adjuvant chemotherapy, with singleagent alkylating and anti-metabolic drugs, was soon replaced by combination therapy, as it was demonstrated that simultaneous combination of two or more agents provided better results. 4, 5) Kalpaamruthaa is a Siddha formulation, which has been formulated in our laboratory. They contain Semecarpus anacardium LINN. (SA), Emblica officinalis and honey with different ratio. Kalpaamruthaa (KA) is a Siddha preparation which has been formulated in our laboratory, the components studies of this drug reveals the presence of flavonoids, ascorbic acid, polyphenols, tannins, sugars and sterols. Flavonoids are seemingly more widely dispersed in the food supply and are of more varied composition than are isoflavones. For these reason, their absorption and metabolism have been less completely characterized. Cameron and Pauling 6) believed that ascorbic acid combats cancer by promoting collagen synthesis and thus prevents tumors from invading other tissues. Flavonoids are polyphenols widely distributed and known to possess biological and pharmacological activities, including anti-inflammatory action against free radicals. 7) Isoflavonoids are members of the broad class of plant polyphenols that have been shown in vivo to have benefit in the treatment of a wide variety of chronic diseases, including cancer. Another important consideration in vivo is the localized metabolism of isoflavones that may occur in the vicinity of tumor cells. Many experiments to verify the association between isoflavone intake and disease prevention have been reported. 8) The biochemical evaluation of glycoprotein components, marker enzymes and lysosomal enzymes of liver, kidney and blood of control and experimental rats was carried out to study the therapeutic efficacy of KA on 7,12-dimethylbenz-(a)anthracene (DMBA) induced mammary carcinoma bearing rats (Sprague-Dawley strain). This study was undertaken to arrive at the effective dose of KA in mammary carcinoma condition in rats.
MATERIALS AND METHODS

Materials
Mammary carcinoma was induced in 8-week old rats by gastric intubation of 7,12-dimethylbenz(a)anthracene (Sigma, St. Louis, MO, U.S.A.; 25 mg/ml). 2 ) . At sacrifice, the volume of each was calculated using its three diameters:
After the experimental period, the animals were sacrificed by cervical decapitation. Liver and kidney were immediately excised from the animals and the organs were weighed accurately and washed well with ice-cold saline and homogenized in Tris-HCl buffer (0.1 M, pH 7.4). Blood was also collected for analyses. Body weight and weight were recorded. Protein was estimated by the method of Lowry et al. 10) Hexose and hexosamine in the aliquots were determined by the method of Niebes 11) and Wagner, 12) respectively. The level of sialic acid was measured by the method of Warren.
13) The levels of lactate dehydrogenase (LDH) and 5Ј nucleotidase (5Ј ND) was estimated by the method of King (a) and Luly et al., 14, 15) respectively. Acid phosphatase and Cathepsin-D was measured by the method of King (b) 16) and Sapolsky, 17) respectively.
Statistical Analysis Values are given as the meansϮS.D. of six rats. The results were statistically evaluated using Student's t-test and ANOVA. Table 1 indicates the changes in the body weight, organ weights and volume during cancer and drug treated condition. The body weight and organ weights such as liver and kidney were significantly decreased (pϽ0.001) whereas the volume was found to be enormously elevated (pϽ0.001) in mammary carcinoma bearing animals. On treatment with KA, the body weight, organ weights and the volume were significantly recouped back to near normal conditions in a dose dependent manner. The dosage level of 300 mg/kg body weight was found to be the effective dose with a significant (pϽ0.001) effect. Table 2 shows the glycoprotein levels in plasma, liver and kidney of control and experimental animals. In mammary carcinoma bearing rats, the protein bound carbohydrate components such as hexose, hexosamine and sialic acid levels were significantly increased (pϽ0.001) when compared to control animals. After treatment, the glycoprotein levels were significantly decreased in drug treated animals in a dose dependant manner when compared to mammary carcinoma bearing rats. The drug treatment at the concentration of 300, 400 and 500 mg/kg showed a highly significant effect (pϽ0.001) when compared with cancer induced animals. Table 3 depicts the activities of lysosomal enzymes namely, acid phosphatase, cathepsin-D in liver and kidney of control and experimental animals. The activities of lysosomal enzymes were found to be significantly increased (pϽ0.001) in carcinoma induced animals than in control animals. On drug treatment, the levels were significantly decreased in a dose dependent manner showing a favorable change in groups treated with 300 mg/kg.
RESULTS
The levels of marker enzymes (LDH, 5ЈND) in plasma, liver and kidney of control and experimental animals were depicted in Table 4 . Activities of marker enzymes were found to be significantly increased in mammary carcinoma bearing animals. There was a significant decrease in the levels of these enzymes in KA treated group animals with a higher significance in 300, 400 and 500 mg/kg treatment.
DISCUSSION
Interest in the use of herbal products has grown dramatically in the Western world. With the narrow therapeutic range associated with most anticancer drugs, there is an increasing need for understanding possible adverse drug interactions in medical oncology. 18) KA is non-toxic and has sev- eral activities that are capable of inhibiting the initiation, development and progression of cancer. In mammary carcinoma bearing animals, there was a sharp drop in their body weight. This may be due to the cancer cachexia. Cancer cachexia results in progressive loss of body weight, which is mainly accounted by wasting of host body compartments such as skeletal muscle and adipose tissue. Weight loss and tissue wasting are observed in cancer patients. 19) The weight loss implies poor prognosis and shorter survival time for cancer patients. 20) On drug treatment, the gradual increase in body weight indicates the counteractive property of the drug. Food rich in polyphenols, flavonoids, catechins could mediate favourable changes due to their antioxidant, immunopotentiating and anti-inflammatory properties. 21) This inhibiting property may be due to the presence of flavonoids, as they have been reported to impart antiproliferative action on several cancer cells. 22) Flavonoids in the KA might influence the studied carcinogenic parameters and might be the main inhibitory representative in the drug. Chakraborty et al., 23) have showed that flavonoid acts as inducers of apoptosis in cells and thus acts as a potent anti-proliferative agent and this strategy suggest their potential use in cancer control. The flavonoid may inhibit growth and cause regression of s via modulating the protein kinases activity and through induction of apoptosis. 24) The mechanism of carcinogen inactivation, antiproliferation, cell cycle arrest, induction of apoptosis on differentiation, inhibition of angiogenesis and antioxidation property of flavonoids may be responsible for growth inhibition. 25) Glycoproteins play a vital role in cell-to-cell recognition, 27) The elevated levels of hexose; hexosamine and sialic acid in cancerous conditions are useful indicators of carcinogenic process, and these changes alter the structure, rigidity and function of cell membranes. 28) In plasma, the increased levels of glycoprotein components in cancer condition may be due to the leakage of the disturbed membrane components from either disintegrating or dying neoplastic cells or as a consequent shedding of plasma membrane. 29) On drug treatment, glycoprotein component levels were reverted back to near normal levels. This could be due to the cytostabilising property of the drug and flavonoids possess inhibitory action against carcinogenesis.
30) The alkaloids and other components of drug may alter the expression of glycosyltransferases and interfere with cell membrane glycoprotein synthesis and structure, indicating its potent anti property. This reduction in the levels of glycoprotein components indicates that the KA has ability to suppress malignancy by modulating cell transformation, decreasing the degree of metastasis, inhibiting the progression of growth, controlling the cancer cell proliferation and differentiation by causing effective favourable changes in the structure of cell membranes. The fruits have been reported to contain constituents with variable biological activity and possess antioxidant, 31) adaptogenic, 32) and hepato-protective 33) and anti-activities. 34) Chrysin is a natural, biologically active compound extracted from many plants, honey. It possesses potent anti-inflammation, anti-cancer and anti-oxidation properties. 35) LDH is a tetrameric enzymes recognized as a marker with potential use in assessing the progression of the proliferating malignant cells. In the present study, the activities of LDH increase in-bearing animals, possibly as a result of over production by cells. 36) LDH is a fairly sensitive marker for solid neoplasm. 37) Numerous reports reveal elevated LDH activity in various types of s. 38) This may be due to the higher glycolysis in the cancerous condition, which is the only energy-producing pathway for the uncontrolled proliferating malignant cells. The results of the current study show that 5Ј-ND activity was elevated in cancerous animals. Dao et al. (1980) 39) have reported that the increased activity of 5Ј-nucleotidase seems to have originated from the proliferating breast cells. This elevation of the marker enzyme may be correlated with the progression of the malignancy. Walia et al. (1995) 40) have reported higher activities of 5Ј-ND in breast cancer patients. 5Ј-ND activity was found to be increased in cancerous breast tissue of patients. 41) The abnormal variation in the marker enzymes reflects the overall change in metabolism that occurs during malignancy. 42) This elevation indicates the severity of the disease, or may be due to the release of enzyme from normal tissue invaded by elements. 43) The altered activities in the drug treated animals can be attributed to the presence of flavonoids. The drug SA contains a number of minerals and vitamins. Analysis of SA revealed the presence of calcium, iron, copper, sodium and aluminium 44) and it's also proved the antiproliferative effects on several cancer cells. 22) Other constituents of the drug namely bhilawanols are mainly localized maximally in cell membrane fraction suggesting their effect through alterations in membrane fractions. KA would change the permeability of the membrane, affecting cellular growth. 45) Lysosomes are a group of cytoplasmic organelles present in numerous animal tissues, characterized by their content of acid hydrolases. These cytoplasmic vesicles contain hydrolytic enzymes that are capable of digesting the macromolecules like polysaccharides, nucleic acids and lipids.
46) The invasion in the cancerous conditions may lead to the elevated activity of lysosomal enzymes. This increase may be due to the abnormal fragility of the lysosomes in the cancerous condition, which depends on the damage of cell membrane due to enormous production of free radicals in the cancerous condition. 47) Cathepsin-D is a useful marker for identifying breast cancer patients with increased risk of recurrent disease.
48) The activity of cathepsin-D of malignant tissues increases approximately 3-folds and 2-folds when compared with normal and benign breast disease tissue, respectively. 49) An increased expression of cathepsin-D in malignant breast tissue when compared to normal breast tissue observed in our investigation is in line with previous reports. 50) Reversion of their levels in drug treated animals may be due to the stabilizing property of the drug on lysosomal membrane which could have been imparted by the flavonoids, as it is well established that flavonoids have inhibiting property on lysosomal membranes. The drug may modify the lysosomal membrane in such a way that it is capable of fusing with the plasma membrane and thereby preventing the discharge of acid hydrolases or by inhibiting the release of lysosomal enzymes. 51) Numerous reports have appeared on the inhibition of acid hydrolases by flavonoids. 52) Studies of cancer treatment in experimental animals have assessed the impact of a wide variety of flavonoids and a selected few isoflavones for their efficacy in inhibiting cancer in a number of animal models. Citrus flavonoids were the focus of studies by So et al. (1996) . 53) The presence of flavonoids has been shown to impart inhibitory action against carcinogenesis.
30) The active principles or extracts of P. emblica have been shown to possess several pharmacologic actions, e.g., antitumor, and cytotoxic activities. 54) Phytoestrogens are phenolic nonsteroidal plant compounds with estrogen-like biological activity. Most flavonoids are nonestrogenic or weakly estrogenic; however, the isoflavones such as genistein, other flavonoids such as apigenin and kaempferol, and the polyphenolic stilbenes such as resveratrol act through estrogen receptor-mediated mechanisms and also have antiestrogenic effects. 55) Polyphenols, which is present in our drug, existing ubiquitously in nature. They exhibit a broad spectrum of biological activities including anti-inflammatory, antiviral, antiatherogenic, antibacterial, as well as anticancer effects. 56, 57) The results of the present of study indicate that Kalpaamruthaa (modified Siddha preparation) possesses strong anticancer effects. This drug exerted a strong anticancer effect in a dose dependent manner and is pronounced at the levels of 300 mg/kg body weight.
